{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:30:16Z","timestamp":1783571416355,"version":"3.55.0"},"reference-count":100,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCDD"],"abstract":"<jats:p>Advancements in cardiac magnetic resonance (CMR) imaging quality and availability have made it an essential tool in the care of individuals living with cardiomyopathies. CMR complements clinical suspicion, electrocardiogram patterns, and echocardiographic findings to help elucidate the etiology of cardiomyopathies and can also be used to prognosticate and follow treatment responses. In this review, we highlight the common CMR findings in cardiac amyloidosis, cardiac sarcoidosis, iron overload cardiomyopathy, and Fabry disease. We also summarize prognostic findings and additional potential roles for CMR in the management of infiltrative cardiomyopathies.<\/jats:p>","DOI":"10.3390\/jcdd12040154","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T03:39:16Z","timestamp":1744601956000},"page":"154","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cardiac Magnetic Resonance Imaging in the Evaluation and Prognosis of Infiltrative Cardiomyopathies"],"prefix":"10.3390","volume":"12","author":[{"given":"Merna","family":"Hussien","sequence":"first","affiliation":[{"name":"Department of Cardiology, MedStar Washington Hospital Center, Washington, DC 20010, USA"},{"name":"School of Medicine, Georgetown University, Washington, DC 20007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2922-9210","authenticated-orcid":false,"given":"Francisca","family":"Bermudez","sequence":"additional","affiliation":[{"name":"School of Medicine, Georgetown University, Washington, DC 20007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick T.","family":"Bering","sequence":"additional","affiliation":[{"name":"Department of Cardiology, MedStar Washington Hospital Center, Washington, DC 20010, USA"},{"name":"School of Medicine, Georgetown University, Washington, DC 20007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8066-949X","authenticated-orcid":false,"given":"Gaby","family":"Weissman","sequence":"additional","affiliation":[{"name":"Department of Cardiology, MedStar Washington Hospital Center, Washington, DC 20010, USA"},{"name":"School of Medicine, Georgetown University, Washington, DC 20007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison G.","family":"Hays","sequence":"additional","affiliation":[{"name":"Department of Cardiology, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9687-9475","authenticated-orcid":false,"given":"Farooq H.","family":"Sheikh","sequence":"additional","affiliation":[{"name":"Department of Cardiology, MedStar Washington Hospital Center, Washington, DC 20010, USA"},{"name":"School of Medicine, Georgetown University, Washington, DC 20007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jacc.2018.01.016","article-title":"Spectrum of Restrictive and Infiltrative Cardiomyopathies","volume":"71","author":"Pereira","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"CMC.S19706","DOI":"10.4137\/CMC.S19706","article-title":"Infiltrative Cardiomyopathies","volume":"9","author":"Bejar","year":"2015","journal-title":"Clin. Med. Insights Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: A position statement from the european society of cardiology working group on myocardial and pericardial diseases","volume":"29","author":"Elliott","year":"2007","journal-title":"Eur. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2174\/157340310791162668","article-title":"Cardiac MRI in Infiltrative Disorders: A Concise Review","volume":"6","author":"Penugonda","year":"2010","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_5","first-page":"129","article-title":"Introduction to Cardiovascular Magnetic Resonance: Technical Principles and Clinical Applications","volume":"32","author":"Tseng","year":"2016","journal-title":"Acta Cardiol. Sin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_7","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Writing Committee, Kittleson, M.M., Ruberg, F.L., Ambardekar, A.V., Brannagan, T.H., Cheng, R.K., Clarke, J.O., Dember, L.M., Frantz, J.G., and Hershberger, R.E. (2023). 2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient with Cardiac Amyloidosis: A Report of the American College of Cardiology Solution Set Oversight Committee. J. Am. Coll. Cardiol., 81, 1076\u20131126.","DOI":"10.1016\/j.jacc.2022.11.022"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.amjcard.2004.10.028","article-title":"Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement","volume":"95","author":"Murtagh","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/0002-9149(87)90948-9","article-title":"Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis","volume":"59","author":"Falk","year":"1987","journal-title":"Am. J. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.amjcard.2008.09.102","article-title":"Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography","volume":"103","author":"Sun","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"ref_12","first-page":"1442","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"Phelan","year":"2012","journal-title":"Heart Br. Card. Soc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jcmg.2015.05.014","article-title":"Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis","volume":"9","author":"Ternacle","year":"2016","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jcmg.2019.10.011","article-title":"Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis","volume":"13","author":"Boldrini","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Scheel, P.J., Mukherjee, M., Hays, A.G., and Vaishnav, J. (2022). Multimodality Imaging in the Evaluation and Prognostication of Cardiac Amyloidosis. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.787618"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.amjcard.2023.09.055","article-title":"Myocardial Work Appraisal in Transthyretin Cardiac Amyloidosis and Nonobstructive Hypertrophic Cardiomyopathy","volume":"208","author":"Trimarchi","year":"2023","journal-title":"Am. J. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Monte, I.P., Faro, D.C., Trimarchi, G., de Gaetano, F., Campisi, M., Losi, V., Teresi, L., Di Bella, G., Tamburino, C., and de Gregorio, C. (2023). Left Atrial Strain Imaging by Speckle Tracking Echocardiography: The Supportive Diagnostic Value in Cardiac Amyloidosis and Hypertrophic Cardiomyopathy. J. Cardiovasc. Dev. Dis., 10.","DOI":"10.3390\/jcdd10060261"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","article-title":"Magnetic Resonance in Transthyretin Cardiac Amyloidosis","volume":"70","author":"Treibel","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcmg.2018.02.006","article-title":"Native T1 and Extracellular Volume in Transthyretin Amyloidosis","volume":"12","author":"Kotecha","year":"2019","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1016\/j.jacc.2018.03.536","article-title":"Myocardial Edema and Prognosis in Amyloidosis","volume":"71","author":"Kotecha","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10741-014-9470-7","article-title":"Cardiovascular magnetic resonance for amyloidosis","volume":"20","author":"Fontana","year":"2015","journal-title":"Heart Fail. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1136\/heartjnl-2012-302346","article-title":"Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease","volume":"98","author":"Sado","year":"2012","journal-title":"Heart"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCIMAGING.112.978627","article-title":"Quantification of Myocardial Extracellular Volume Fraction in Systemic AL Amyloidosis","volume":"6","author":"Banypersad","year":"2013","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12968-017-0376-0","article-title":"Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics","volume":"19","author":"Williams","year":"2017","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00380-017-1043-y","article-title":"Right ventricular involvement evaluated by cardiac magnetic resonance imaging predicts mortality in patients with light chain amyloidosis","volume":"33","author":"Wan","year":"2018","journal-title":"Heart Vessels"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.amjcard.2008.09.105","article-title":"Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis","volume":"103","author":"Ruberg","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jcmg.2017.02.012","article-title":"CMR-Verified Regression of Cardiac AL Amyloid After Chemotherapy","volume":"11","author":"Treibel","year":"2018","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: Baseline clinical manifestations of 366 patients in the Fabry Outcome Survey","volume":"34","author":"Mehta","year":"2004","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","article-title":"An atypical variant of Fabry\u2019s disease in men with left ventricular hypertrophy","volume":"333","author":"Nakao","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCGENETICS.109.862920","article-title":"High Incidence of the Cardiac Variant of Fabry Disease Revealed by Newborn Screening in the Taiwan Chinese Population","volume":"2","author":"Lin","year":"2009","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.CIR.0000012626.81324.38","article-title":"Prevalence of Anderson-Fabry Disease in Male Patients with Late Onset Hypertrophic Cardiomyopathy","volume":"105","author":"Sachdev","year":"2002","journal-title":"Circulation"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/01.CIR.0000139847.74101.03","article-title":"Prevalence of Fabry Disease in Female Patients with Late-Onset Hypertrophic Cardiomyopathy","volume":"110","author":"Chimenti","year":"2004","journal-title":"Circulation"},{"key":"ref_35","first-page":"790","article-title":"Life expectancy and cause of death in males and females with Fabry disease: Findings from the Fabry Registry","volume":"11","author":"Waldek","year":"2009","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/eurheartj\/ehm153","article-title":"European FOS Investigators Cardiac manifestations of Anderson-Fabry disease: Results from the international Fabry outcome survey","volume":"28","author":"Linhart","year":"2007","journal-title":"Eur. Heart J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jacc.2011.03.020","article-title":"Exercise-Induced Left Ventricular Outflow Tract Obstruction in Symptomatic Patients with Anderson-Fabry Disease","volume":"58","author":"Calcagnino","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1136\/hrt.2010.204586","article-title":"The right ventricle in Fabry disease: Natural history and impact of enzyme replacement therapy","volume":"96","author":"Niemann","year":"2010","journal-title":"Heart Br. Card. Soc."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/echo.13496","article-title":"Loss of base-to-apex circumferential strain gradient: A specific pattern of Fabry cardiomyopathy?","volume":"34","author":"Labombarda","year":"2017","journal-title":"Echocardiography"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jcmg.2018.11.039","article-title":"The Role of Cardiac Imaging in the Diagnosis and Management of Anderson-Fabry Disease","volume":"12","author":"Perry","year":"2019","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Esposito, R., Santoro, C., Mandoli, G.E., Cuomo, V., Sorrentino, R., La Mura, L., Pastore, M.C., Bandera, F., D\u2019Ascenzi, F., and Malagoli, A. (2021). Cardiac Imaging in Anderson-Fabry Disease: Past, Present and Future. J. Clin. Med., 10.","DOI":"10.3390\/jcm10091994"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12968-022-00859-z","article-title":"Cardiovascular magnetic resonance native T1 mapping in Anderson-Fabry disease: A systematic review and meta-analysis","volume":"24","author":"Ponsiglione","year":"2022","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12968-014-0099-4","article-title":"Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance","volume":"16","author":"Pica","year":"2014","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCIMAGING.112.000070","article-title":"Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping","volume":"6","author":"Sado","year":"2013","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12968-016-0233-6","article-title":"Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry disease","volume":"18","author":"Deva","year":"2016","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1148\/radiol.2019191385","article-title":"Left Ventricular Hypertrophy and Late Gadolinium Enhancement at Cardiac MRI Are Associated with Adverse Cardiac Events in Fabry Disease","volume":"294","author":"Hanneman","year":"2020","journal-title":"Radiology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jacc.2022.06.022","article-title":"Validated Model for Prediction of Adverse Cardiac Outcome in Patients with Fabry Disease","volume":"80","author":"Orsborne","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13023-015-0338-2","article-title":"Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: Cardiac outcomes after 10 years\u2019 treatment","volume":"10","author":"Kampmann","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry Disease, an Under-Recognized Multisystemic Disorder: Expert Recommendations for Diagnosis, Management, and Enzyme Replacement Therapy","volume":"138","author":"Desnick","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.jpeds.2009.07.003","article-title":"Guidelines to Diagnosis and Monitoring of Fabry Disease and Review of Treatment Experiences","volume":"155","author":"Martins","year":"2009","journal-title":"J. Pediatr."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/ejhf.1960","article-title":"An expert consensus document on the management of cardiovascular manifestations of Fabry disease","volume":"22","author":"Linhart","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_52","first-page":"205","article-title":"Iron overload disorders: Natural history, pathogenesis, diagnosis, and therapy","volume":"19","author":"McLaren","year":"1983","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/S0268-960X(08)70004-3","article-title":"Cardiac iron across different transfusion-dependent diseases","volume":"22","author":"Wood","year":"2008","journal-title":"Blood Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2008-04-148767","article-title":"Longitudinal analysis of heart and liver iron in thalassemia major","volume":"112","author":"Noetzli","year":"2008","journal-title":"Blood"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0002-9343(71)90240-3","article-title":"Iron in the heart: Etiology and clinical significance","volume":"51","author":"Buja","year":"1971","journal-title":"Am. J. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.111.050773","article-title":"Iron Overload Cardiomyopathy in Clinical Practice","volume":"124","author":"Kremastinos","year":"2011","journal-title":"Circulation"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"522","DOI":"10.7326\/0003-4819-143-7-200510040-00011","article-title":"Screening primary care patients for hereditary hemochromatosis with transferrin saturation and serum ferritin level: Systematic review for the American College of Physicians","volume":"143","author":"Schmitt","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ajh.22205","article-title":"Electrocardiographic consequences of cardiac iron overload in thalassemia major","volume":"87","author":"Detterich","year":"2012","journal-title":"Am. J. Hematol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/archinte.1969.00300140079018","article-title":"Atrioventricular block in familial hemochromatosis treated by permanent synchronous pacemaker","volume":"123","author":"Aronow","year":"1969","journal-title":"Arch. Intern. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/01.CIR.82.1.88","article-title":"Restrictive diastolic abnormalities identified by Doppler echocardiography in patients with thalassemia major","volume":"82","author":"Spirito","year":"1990","journal-title":"Circulation"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e818","DOI":"10.1542\/peds.2005-0843","article-title":"Changes in the epidemiology of thalassemia in North America: A new minority disease","volume":"116","author":"Vichinsky","year":"2005","journal-title":"Pediatrics"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4103\/JCPC.JCPC_16_17","article-title":"Assessment of Regional and Global Myocardial Systolic Function by 2D Longitudinal Speckle Tracking in Children with Beta Thalassemia Major","volume":"6","author":"Narayana","year":"2017","journal-title":"J. Clin. Prev. Cardiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12574-021-00524-x","article-title":"Advancement of echocardiography for surveillance of iron overload cardiomyopathy: Comparison to cardiac magnetic resonance imaging","volume":"19","author":"Zimmerman","year":"2021","journal-title":"J. Echocardiogr."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/euhj.2001.2709","article-title":"Right ventricular cardiomyopathy in \u03b2-thalassaemia major","volume":"23","author":"Hahalis","year":"2002","journal-title":"Eur. Heart J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MOH.0b013e3280d2b76b","article-title":"Magnetic resonance imaging measurement of iron overload","volume":"14","author":"Wood","year":"2007","journal-title":"Curr. Opin. Hematol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.110.007641","article-title":"On T2* Magnetic Resonance and Cardiac Iron","volume":"123","author":"Carpenter","year":"2011","journal-title":"Circulation"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","article-title":"Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload","volume":"22","author":"Anderson","year":"2001","journal-title":"Eur. Heart J."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Torlasco, C., Cassinerio, E., Roghi, A., Faini, A., Capecchi, M., Abdel-Gadir, A., Giannattasio, C., Parati, G., Moon, J.C., and Cappellini, M.D. (2018). Role of T1 mapping as a complementary tool to T2* for non-invasive cardiac iron overload assessment. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0192890"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12968-021-00765-w","article-title":"Myocardial iron overload by cardiovascular magnetic resonance native segmental T1 mapping: A sensitive approach that correlates with cardiac complications","volume":"23","author":"Meloni","year":"2021","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1136\/hrt.2008.156497","article-title":"Myocardial scarring by delayed enhancement cardiovascular magnetic resonance in thalassaemia major","volume":"95","author":"Pepe","year":"2009","journal-title":"Heart Br. Card. Soc."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Meloni, A., Pistoia, L., Gamberini, M.R., Cuccia, L., Lisi, R., Cecinati, V., Ricchi, P., Gerardi, C., Restaino, G., and Righi, R. (2023). Multi-Parametric Cardiac Magnetic Resonance for Prediction of Heart Failure Death in Thalassemia Major. Diagnostics, 13.","DOI":"10.3390\/diagnostics13050890"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1161\/CIRCULATIONAHA.109.874487","article-title":"Cardiac T2* Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major","volume":"120","author":"Kirk","year":"2009","journal-title":"Circulation"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3324\/haematol.10455","article-title":"Cardiac magnetic resonance imaging R2* assessments and analysis of historical parameters in patients with transfusion-dependent thalassemia","volume":"92","author":"Aessopos","year":"2007","journal-title":"Haematologica"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3324\/haematol.2010.025510","article-title":"Cardiac iron and cardiac disease in males and females with transfusion-dependent thalassemia major: A T2* magnetic resonance imaging study","volume":"96","author":"Marsella","year":"2011","journal-title":"Haematologica"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of Sarcoidosis and Its Management","volume":"385","author":"Drent","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","article-title":"Racial Differences in Sarcoidosis Incidence: A 5-Year Study in a Health Maintenance Organization","volume":"145","author":"Rybicki","year":"1997","journal-title":"Am. J. Epidemiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1056\/NEJM199704243361706","article-title":"Sarcoidosis","volume":"336","author":"Newman","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/MCP.0000000000000715","article-title":"Sarcoidosis epidemiology: Recent estimates of incidence, prevalence and risk factors","volume":"26","author":"Arkema","year":"2020","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"key":"ref_81","first-page":"372","article-title":"Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan","volume":"43","author":"Iwai","year":"1993","journal-title":"Acta Pathol. Jpn."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","article-title":"Cardiac Sarcoidosis","volume":"68","author":"Birnie","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cardfail.2021.06.016","article-title":"Sarcoidosis-Related Cardiomyopathy: Current Knowledge, Challenges, and Future Perspectives State-of-the-Art Review","volume":"28","author":"Gilotra","year":"2022","journal-title":"J. Card. Fail."},{"key":"ref_84","first-page":"89","article-title":"Diagnostic standard and guidelines for sarcoidosis","volume":"27","author":"Hiraga","year":"2007","journal-title":"Jpn J Sarcoidosis Granulomatous Disord."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated with Cardiac Sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Wand, A.L., Chrispin, J., Saad, E., Mukherjee, M., Hays, A.G., and Gilotra, N.A. (2021). Current State and Future Directions of Multimodality Imaging in Cardiac Sarcoidosis. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.785279"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ejhf.205","article-title":"Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis","volume":"17","author":"Joyce","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/eurheartj\/ehad067","article-title":"Cardiac sarcoidosis: Phenotypes, diagnosis, treatment, and prognosis","volume":"44","author":"Lehtonen","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/0002-9149(89)90323-8","article-title":"Two-dimensional echocardiographic findings in systemic sarcoidosis","volume":"63","author":"Burstow","year":"1989","journal-title":"Am. J. Cardiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ccm.2008.03.005","article-title":"Cardiac Sarcoidosis","volume":"29","author":"Ayyala","year":"2008","journal-title":"Clin. Chest Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e000867","DOI":"10.1161\/CIRCIMAGING.113.000867","article-title":"Evaluation of Known or Suspected Cardiac Sarcoidosis","volume":"9","author":"Blankstein","year":"2016","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e005022","DOI":"10.1161\/CIRCIMAGING.116.005022","article-title":"Comprehensive Cardiovascular Magnetic Resonance Assessment in Patients with Sarcoidosis and Preserved Left Ventricular Ejection Fraction","volume":"9","author":"Greulich","year":"2016","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e001728","DOI":"10.1136\/openhrt-2021-001728","article-title":"T2-weighted short-tau-inversion-recovery imaging reflects disease activity of cardiac sarcoidosis","volume":"8","author":"Aoki","year":"2021","journal-title":"Open Heart"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/RTI.0b013e3182761830","article-title":"Late Gadolinium Enhancement in Cardiac Sarcoidosis: Characteristic Magnetic Resonance Findings and Relationship with Left Ventricular Function","volume":"28","author":"Watanabe","year":"2013","journal-title":"J. Thorac. Imaging"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/eurheartj\/ehi258","article-title":"Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies","volume":"26","author":"Mahrholdt","year":"2005","journal-title":"Eur. Heart J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e007030","DOI":"10.1161\/CIRCIMAGING.117.007030","article-title":"Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography\/Computed Tomography in the Assessment of Cardiac Sarcoidosis","volume":"11","author":"Vita","year":"2018","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e011253","DOI":"10.1161\/JAHA.118.011253","article-title":"Myocardial Involvement in Patients with Histologically Diagnosed Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis of Gross Pathological Images from Autopsy or Cardiac Transplantation Cases","volume":"8","author":"Okasha","year":"2019","journal-title":"J. Am. Heart Assoc. Cardiovasc. Cerebrovasc. Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR Imaging Predicts Death and Other Adverse Events in Suspected Cardiac Sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e005001","DOI":"10.1161\/CIRCIMAGING.116.005001","article-title":"Presence of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Among Patients with Suspected Cardiac Sarcoidosis Is Associated with Adverse Cardiovascular Prognosis: A Systematic Review and Meta-Analysis","volume":"9","author":"Hulten","year":"2016","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jcmg.2022.11.012","article-title":"Prognostic Value of RV Abnormalities on CMR in Patients with Known or Suspected Cardiac Sarcoidosis","volume":"16","author":"Wang","year":"2023","journal-title":"JACC Cardiovasc. Imaging"}],"container-title":["Journal of Cardiovascular Development and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3425\/12\/4\/154\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:13:19Z","timestamp":1760029999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3425\/12\/4\/154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,12]]},"references-count":100,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["jcdd12040154"],"URL":"https:\/\/doi.org\/10.3390\/jcdd12040154","relation":{},"ISSN":["2308-3425"],"issn-type":[{"value":"2308-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,12]]}}}